BioMed Research International
Volume 2019 (2019), Article ID 9042956, 1 page
https://doi.org/10.1155/2019/9042956

Corrigendum

Corrigendum to “A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation”

Valerio Mezzasalma,¹ Enrico Manfrini,¹ Emanuele Ferri,¹ Anna Sandionigi,¹ Barbara La Ferla,¹ Irene Schiano,² Angela Michelotti,² Vincenzo Nobile,² Massimo Labra,¹ and Patrizia Di Gennaro¹

¹Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milan, Italy
²Farcoderm Srl., Via Angelini 21, San Martino Siccomario, 27028 Pavia, Italy

Correspondence should be addressed to Patrizia Di Gennaro; patrizia.digennaro@unimib.it

Received 26 February 2019; Accepted 3 March 2019; Published 9 April 2019

Copyright © 2019 Valerio Mezzasalma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation” [1], the number of probiotics in the formulation mixtures in subsection “2.1. Study Design” in Materials and Methods was written incorrectly as follows:

“The composition of the probiotic mix F_1 was as follows: 5 × 10⁹ CFU L. acidophilus (30 mg as lyophilized), 5 × 10⁹ CFU L. reuteri (30 mg as lyophilized), 330 mg inulin, 5 mg silica, and 5 mg talc. The F_2 composition was as follows: 5 × 10⁹ CFU L. plantarum (12 mg as lyophilized), 5 × 10⁹ CFU L. rhamnosus (20 mg as lyophilized), 5 × 10⁹ CFU B. animalis subsp. lactis (60 mg as lyophilized), 298 mg inulin, 5 mg silica, and 5 mg talc. Placebo (F_3) composition was as follows: 390 mg inulin, 5 mg silica, 5 mg talc.”

It should be corrected to the following: “The composition of the probiotic mix F_1 was as follows: 2 × 10⁹ CFU L. acidophilus (30 mg as lyophilized), 2 × 10⁹ CFU L. reuteri (30 mg as lyophilized), 330 mg inulin, 5 mg silica, and 5 mg talc. The F_2 composition was as follows: 2 × 10⁹ CFU L. plantarum (12 mg as lyophilized), 2 × 10⁹ CFU L. rhamnosus (20 mg as lyophilized), 2 × 10⁹ CFU B. animalis subsp. lactis (60 mg as lyophilized), 298 mg inulin, 5 mg silica, and 5 mg talc. Placebo (F_3) composition was as follows: 390 mg inulin, 5 mg silica, and 5 mg talc.”

References

V. Mezzasalma, E. Manfrini, E. Ferri et al., “A randomized, double-blind, placebo-controlled trial: the efficacy of multispecies probiotic supplementation in alleviating symptoms of irritable bowel syndrome associated with constipation,” BioMed Research International, vol. 2016, Article ID 4740907, 10 pages, 2016.